BPG致力于知识的发现和传播
Home / Archive / Volume 31, Issue 40
  • 本文章
本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
  • 本文章浏览次数 (1391)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-1) series.
Item 
Count 
PDF111
HTML400
Tables (1-1)33
 总和 = 544
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse228
Download201
 总和 = 429
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse134
Download171
 总和 = 305
Oct 28, 2025 (publication date) through Jan 31, 2026
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Gastroenterology
ISSN
1007-9327
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

在F6Publishing中引用其的文章
For: Isakov V, Goncharov A. Breaking barriers in the first-line Helicobacter pylori treatment: Chinese multicenter trial validates vonoprazan-based triple therapy. World J Gastroenterol 2025; 31(40): 112312 [PMID: 41180991 DOI: 10.3748/wjg.v31.i40.112312]
URL: https://www.wjgnet.com/1009-3079/full/v31/i40/112312.htm
编号 Citing Articles
1
Chao-Qun Wu, Xiu Zhou, Chang-Ping Li, Qing-Ling He, Zong-Hua Chen, Shun-Bin Ding, Lei Deng, Lin-Lin Chen, Kai Jiang, Cheng-Kui Dong, Lian Hu, Guo-Bing Zhu, Cheng-Gang Zhang, Yan Zhang, Li-Li Wu, Wei Li, Yi-Hong Mao, Hua Zhang, Xia Ai, Yuan-Qing He, Yan Ma, Shuang-Yan He. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for <i>Helicobacter pylori</i> eradication in Sichuan Province, China. World Journal of Gastroenterology 2025; 31(47): 114377 doi: 10.3748/wjg.v31.i47.114377
写信给帮助平台
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345